Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for Relapse Prevention in First Episode MCNS
NCT03970577Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2020
- Primary completion
- Nov 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in nephrosis, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
rituximab
03
Conditions
nephrosis
Beyond the preview
Go deeper on NCT03970577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970577.